BioClinica to merge with California company

BioClinica Inc., of Newtown, said it will merge with Newark, Calif.-based CCBR-SYNARC.

BioClinica manages clinical trials in the U.S., Europe and Asia, while CCBR-SYNARC is described as a provider of clinical services to pharmaceutical and biotechnology companies.

Financial terms and other details of the merger were not disclosed. The privately held companies expect the deal to close in the first quarter.

A name has not yet been chosen for the merged company, which will have 1,250 employees, a spokesman said. Mark Weinstein, president & CEO of BioClinica, will serve as CEO of the new company. - Reid Kanaley